Article summary
Massachusetts advances a psychedelic therapy pilot program, the FDA finalizes its psychedelic trial guidance and sets a September hearing, the WNBA bans multiple psychedelics, France doses its first Phase III psilocybin participant, and a British chemist faces US extradition. The post Psychedelic Policy Briefing: Week of July 13th, 2026 appeared first on Psychedelics Today.
Continue to the original publication for the complete article.